Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-73
Closed -$8.22K 352
2023
Q2
$8.22K Hold
73
﹤0.01% 277
2023
Q1
$7.64K Hold
73
﹤0.01% 284
2022
Q4
$8K Hold
73
﹤0.01% 293
2022
Q3
$6K Hold
73
﹤0.01% 304
2022
Q2
$6K Hold
73
﹤0.01% 315
2022
Q1
$6K Hold
73
﹤0.01% 323
2021
Q4
$9K Hold
73
﹤0.01% 293
2021
Q3
$9K Hold
73
﹤0.01% 290
2021
Q2
$9K Hold
73
﹤0.01% 292
2021
Q1
$8K Hold
73
﹤0.01% 291
2020
Q4
$7K Hold
73
﹤0.01% 286
2020
Q3
$6K Hold
73
﹤0.01% 280
2020
Q2
$5K Hold
73
﹤0.01% 297
2020
Q1
$5K Hold
73
﹤0.01% 295
2019
Q4
$6K Hold
73
﹤0.01% 289
2019
Q3
$6K Buy
+73
New +$5.74K ﹤0.01% 295

Other funds holding XYL

Arrow Financial's XYL Position: Q3 2023 in Review

Arrow Financial sold out of Xylem (XYL) in Q3 2023, closing a stake of 73 shares — an estimated $8.22K sold.

Arrow Financial first reported a position in XYL in Q3 2019 and held it in 16 quarters. The position peaked at $9K in Q4 2021. 873 funds tracked by Wall St. Rank hold XYL as of Q3 2023.

  • Arrow Financial reported no remaining Xylem position as of Q3 2023 after selling out during the quarter.
  • Arrow Financial sold 73 Xylem shares in Q3 2023, an estimated $8.22K.
  • Arrow Financial first reported a position in Xylem in Q3 2019 and held it in 16 quarters.
  • Arrow Financial's Xylem position peaked at $9K in Q4 2021.
  • 873 funds tracked by Wall St. Rank held Xylem as of Q3 2023.

Based on Arrow Financial's 13F filing for Q3 2023, filed 13 Nov 2023.